☆ 4.6 Article

Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis A Large Multicenter Cohort Study

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

CSF Kappa Free Light Chains: Cutoff Validation for Diagnosing Multiple Sclerosis

Ruba S. Saadeh et al.

Summary: The study aims to determine and validate a cerebrospinal fluid (CSF) k (KCSF) value comparable to the detection of cerebrospinal fluid-specific oligoclonal bands (OCB) for diagnosing multiple sclerosis (MS). The results show that a KCSF value of 0.1 mg/dL can be used as a valid alternative to OCB testing, providing a standardized quantitative measure with similar sensitivity and specificity, and reducing human error and cost.

MAYO CLINIC PROCEEDINGS (2022)

添加到收藏夹

Article Immunology

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities

Michael Levraut et al.

Summary: This study aimed to analyze the concentrations of several cytokines in cerebrospinal fluid (CSF) and correlate them with the final diagnosis in patients with brain white matter hyperintensities (WMH). The results showed that CSF KFLC index and KFLC fraction were helpful in diagnosing multiple sclerosis and related disorders, while elevated CSF CD25 and IL-6 concentrations could rule out multiple sclerosis.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Clinical Neurology

The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria

Georgina Arrambide et al.

Summary: Arrambide et al. demonstrate that the kappa free light chain index performs similarly to oligoclonal bands for assessing multiple sclerosis risk and diagnostic accuracy. They propose including the kappa free light chain index in the diagnostic criteria for multiple sclerosis due to its ease of determination compared to oligoclonal bands.

BRAIN (2022)

添加到收藏夹

Review Clinical Neurology

Role of B Cells in Multiple Sclerosis and Related Disorders

Giancarlo Comi et al.

Summary: Selective B-cell depletion in patients with relapsing multiple sclerosis and primary progressive MS has led to a conceptual shift in understanding the pathogenesis of MS, highlighting the essential role of B cells in both inflammatory and neurodegenerative components of the disease.

ANNALS OF NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients

M. C. Kowarik et al.

Summary: Natalizumab and fingolimod have differential effects on B cell populations in multiple sclerosis, with fingolimod treatment contracting peripheral blood B cells while natalizumab treatment expands them. The clonal overlap between CSF and PB B cells is reduced with natalizumab but remains stable with fingolimod therapy. These findings suggest that the two therapies have distinct impacts on the exchange and clonal expansion of B cells in MS patients.

NEUROTHERAPEUTICS (2021)

添加到收藏夹

Article Cell Biology

Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern

Malte Johannes Hannich et al.

Summary: In this study, researchers investigated the synthesis of intrathecal FLC-k in cerebrospinal fluid samples from 296 patients. They found that FLC-k synthesis can occur independently of the antibody class produced, and can help distinguish between an inflammatory process and blood contamination. This suggests that additional determination of FLC-k in quotient diagrams may aid in clinical diagnostics.

CELLS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation

Igal Rosenstein et al.

Summary: The Kappa free light chain (KFLC) index shows high sensitivity and specificity in the diagnosis of multiple sclerosis (MS), with similar accuracy to OCB and KFLCIF. Furthermore, the KFLC index is not influenced by disease-modifying therapy, demographic factors, or other inflammatory or degenerative processes in the cerebrospinal fluid.

JOURNAL OF NEUROCHEMISTRY (2021)

添加到收藏夹

Article Clinical Neurology

Evaluation of Kappa Index as a Tool in the Diagnosis of Multiple Sclerosis: Implementation in Routine Screening Procedure

Carmen Teresa Sanz Diaz et al.

Summary: In this study, the performance of CSF K-FLC and K-Index in the diagnosis of multiple sclerosis (MS) was evaluated. The K-Index was found to have higher sensitivity in screening for MS, and it could serve as a potential diagnostic biomarker.

FRONTIERS IN NEUROLOGY (2021)

添加到收藏夹

Article Clinical Neurology

Kappa-Free Light Chains in CSF Predict Early Multiple Sclerosis Disease Activity

Klaus Berek et al.

Summary: The study demonstrates that high κ-FLC index is an independent predictor for disease activity in early multiple sclerosis. Among patients with early MS, high κ-FLC index is a significant risk factor for early second clinical attack.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

添加到收藏夹

Review Clinical Neurology

The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid

Franz F. Konen et al.

Summary: The study found that decreased renal function leads to a decline in KFLC indices and KFLC IF values, affecting the interpretation of KFLC results in patients with neuroinflammatory diseases. In samples with inflammatory CSF profiles, false negative KFLC results may occur.

JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2021)

添加到收藏夹

Article Clinical Neurology

Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study

C. E. Leurs et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

添加到收藏夹

Article Clinical Neurology

Cerebrospinal fluid kappa and lambda free light chains in oligoclonal band-negative patients with suspected multiple sclerosis

D. Ferraro et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

添加到收藏夹

Article Immunology

Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis

Lorenzo Gaetani et al.

JOURNAL OF NEUROIMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders

P. Cavalla et al.

JOURNAL OF NEUROIMMUNOLOGY (2020)

添加到收藏夹

Article Medical Laboratory Technology

Diagnostic value of kappa free light chains in patients with one isolated band in isoelectric focusing

Marie Suesse et al.

CLINICA CHIMICA ACTA (2020)

添加到收藏夹

Article Immunology

Free light chain kappa and the polyspecific immune response in MS and CIS - Application of the hyperbolic reference range for most reliable data interpretation

Marie Suesse et al.

JOURNAL OF NEUROIMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse

Manuel Salavisa et al.

JOURNAL OF NEUROIMMUNOLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Free light chains kappa can differentiate between myelitis and noninflammatory myelopathy

Marie Suesse et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders

Diana Ferraro et al.

DIAGNOSTICS (2020)

添加到收藏夹

Article Medical Laboratory Technology

Intrathecal immunoglobulin synthesis: The potential value of an adjunct test

Andreja Emersic et al.

CLINICA CHIMICA ACTA (2019)

添加到收藏夹

Article Medical Laboratory Technology

Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis

Harald Hegen et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)

添加到收藏夹

Review Clinical Neurology

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines

Massimo Filippi et al.

BRAIN (2019)

添加到收藏夹

Article Medical Laboratory Technology

Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams

Hansotto Reiber et al.

CLINICA CHIMICA ACTA (2019)

添加到收藏夹

Review Immunology

Validation and meta-analysis of kappa index biomarker in multiple sclerosis diagnosis

Paloma Menendez-Valladares et al.

AUTOIMMUNITY REVIEWS (2019)

添加到收藏夹

Review Clinical Neurology

Misdiagnosis of multiple sclerosis Impact of the 2017 McDonald criteria on clinical practice

Andrew J. Solomon et al.

NEUROLOGY (2019)

添加到收藏夹

Article Immunology

CSF Free Light Chains as a Marker o Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort

Makbule Senel et al.

FRONTIERS IN IMMUNOLOGY (2019)

添加到收藏夹

Article Clinical Neurology

The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+T lymphocytes and B cells

Joana Machado-Santos et al.

BRAIN (2018)

添加到收藏夹

Article Medical Laboratory Technology

Cerebrospinal fluid free light chains as diagnostic biomarker in neuroborreliosis

Harald Hegen et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)

添加到收藏夹

Article Clinical Neurology

Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis

Emma Rathbone et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)

添加到收藏夹

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

添加到收藏夹

Review Immunology

Reassessing B cell contributions in multiple sclerosis

Rui Li et al.

NATURE IMMUNOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis

Philipp Schwenkenbecher et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

添加到收藏夹

Article Pathology

Performance Evaluation of Serum Free Light Chain Analysis Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents

Anne-Sophie Messiaen et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)

添加到收藏夹

Article Clinical Neurology

Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study

Stefan Presslauer et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

添加到收藏夹

Article Clinical Neurology

Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study

Stefan Presslauer et al.

MULTIPLE SCLEROSIS JOURNAL (2016)

添加到收藏夹

Article Pathology

Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay

S. C. Sasson et al.

PATHOLOGY (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis

Gleb Makshakov et al.

PLOS ONE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis

Makbule Senel et al.

PLOS ONE (2014)

添加到收藏夹

Article Immunology

Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis

Fabio Duranti et al.

JOURNAL OF NEUROIMMUNOLOGY (2013)

添加到收藏夹

Article Clinical Neurology

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

Charlotte Teunissen et al.

MULTIPLE SCLEROSIS JOURNAL (2013)

添加到收藏夹

Letter Medical Laboratory Technology

Interlaboratory reproducibility of lsoelectric focusing in oligoclonal band detection

Diego Franciotta et al.

CLINICAL CHEMISTRY (2007)

添加到收藏夹

Article Medicine, Research & Experimental

Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs

Chaya S. Moskowitz et al.

CLINICAL TRIALS (2006)

添加到收藏夹

Review Clinical Neurology

Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis -: A consensus statement

MS Freedman et al.

ARCHIVES OF NEUROLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.